Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas

NCT02177825 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class

Stopped Slow accrual 5 patients out of 25 expected. Primary objectives could not be met without recruiting more patients.

Conditions

Interventions

Sponsor

St. Justine's Hospital